Routine auditor change with no red flags — no trading implications. Monitor next 20-F for any unexpected audit-related disclosures, but this filing alone does not warrant action.
Price Chart
Executive Summary
Dr. Reddy's Laboratories filed a Form 6-K reporting a routine auditor change from Ernst & Young Associates LLP to Deloitte Haskins & Sells LLP, driven by mandatory rotation under Indian law. The filing confirms no disagreements, adverse opinions, or reportable events with the prior auditor, and EY has agreed with the company's statements. This is a standard governance update with no material financial or operational implications.
Key Facts
- Auditor change from Ernst & Young Associates LLP to Deloitte Haskins & Sells LLP, effective for FY2027 audit
- Mandatory rotation under Section 139 of the Indian Companies Act, 2013
- No disagreements or reportable events with prior auditor during FY2026 or FY2025
- Prior auditor's audit reports contained no adverse opinion, disclaimer, or qualification
- Deloitte appointment approved by Board on July 22, 2026, subject to shareholder approval
Financial Impact
No financial impact — routine auditor change with no disagreements or restatements
Risk Factors
- None material — auditor change is mandatory and uncontested
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000528 |
| Document: 0001575872-26-000528-index.html | 0001575872-26-000528 |
| Document: 0001575872-26-000528.txt | 0001575872-26-000528 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $11.91 $11.55 | ▼ −3.02% | ▼ −2.56% | $12.25 (+2.85%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Aug 26, 2026 5w ago | 6-K | $12.22 $12.16 | ▼ −0.49% | ▼ −1.15% | $12.25 (+0.25%) |
Aug 17, 2026 6w ago | 6-K | $12.11 $12.15 | ▲ +0.33% | ▲ +1.01% | $12.25 (+1.16%) |
Aug 13, 2026 7w ago | 6-K | $12.42 $12.27 | ▼ −1.21% | ▼ −1.01% | $12.25 (−1.37%) |
Aug 10, 2026 7w ago | 6-K | $12.15 $12.45 | ▲ +2.47% | ▲ +2.79% | $12.25 (+0.82%) |
Aug 3, 2026 8w ago | 6-K | $12.07 $12.10 | ▲ +0.25% | ▼ −1.55% | $12.25 (+1.49%) |
Jul 29, 2026 9w ago | 6-K | $11.76 $11.83 | ▲ +0.60% | ▼ −1.08% | $12.25 (+4.17%) |
Jul 23, 2026 10w ago | 6-K | $11.80 $11.79 | ▼ −0.08% | ▼ −0.19% | $12.25 (+3.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access